Biotech company targets South America and Africa as part of global expansion goals
Columbus, OH, August 30, 2016 – Cleobrothers & Co., Inc. announced that it has recently opened a sales and marketing office in Salvador, Bahia, Brazil as part of its global expansion plan for promoting and distributing pharmaceuticals and hi-tech medical devices in South America, Asia, Africa and the Middle East.
According to Mr. Innocent Nweze, CEO of Cleobrothers and Co. Inc., “With a population exceeding 200 million people, Brazil provides tremendous potential for launching our brand of over-the-counter medications to retail and medical markets.”
In addition, Cleobrothers offers a pipeline of two first-in-class technologies — a 24/7 proprietary Pregnancy Monitoring device and a new Combination Pharmaceutical for management of Type-2 Diabetes. Both technologies are currently in clinical trials with product launches planned for the first quarter of 2017.
The new office will be located at Av. Tancredo Neves, 450-15° andar, 16th Floor, Caminho das Árvores Salvador, BA 41819-900, Brazil. Phone: +55 (71) 3340-0600. “Having access to U.S. manufactured and FDA approved medications adds a strong competitive advantage to our sales and marketing efforts in Brazil”, Mr. Nweze added.The Brazilian office opening comes on the heels of the company’s recent announcement of a joint venture agreement with PGC Solutions, Ltd. to distribute, market and promote Cleobrothers branded products in Nigeria.
Cleobrothers & Co., Inc. is a Columbus based biotechnology company focused on researching and developing medical and healthcare innovations that are dedicated to helping people worldwide live better lives.